SCHEMBL8201883

SCHEMBL8201883

Nc1cccc(NC(=O)N2CCC3(CC2)C(=O)N(c2cccc(F)c2)C3c2ccc(Cl)cc2)c1

nearest known ligand 0.81

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CACNA1H O95180 20/20 0.81

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8202554 0.92 CACNA1H (0.85) CACNA1H
SCHEMBL8202132 0.90 CACNA1H (1.00) CACNA1H
SCHEMBL12876244 0.88 CACNA1H (1.00) CACNA1H
SCHEMBL8205337 0.88 CACNA1H (0.77) CACNA1H
SCHEMBL8202683 0.83 CACNA1H (0.72) CACNA1H
SCHEMBL8201888 0.82 CACNA1H (0.73) CACNA1H
SCHEMBL8214075 0.82 CACNA1H (0.73) CACNA1H
SCHEMBL8209885 0.81 CACNA1H (0.84) CACNA1H
SCHEMBL14263416 0.81 CACNA1H (0.70) CACNA1H
SCHEMBL8209940 0.80 TRPV1 (0.71) CACNA1H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008033464-A2 AZETIDINONE DERIVATIVES FOR THE TREATMENT OF DISORDERS OF THE LIPID METABOLISM SCHERING CORPORATION (US) 2008-03-20 WO disclosed